Clinical Trial Update: Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation [Phase 1]

View source ↗

Summary

A Phase 1 trial of tolfenamic acid with gemcitabine and radiation for locally advanced or metastatic pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Tolfenamic acid (tolfenamic acid)

Snippet

Sponsor: Orlando Health, Inc. | Conditions: Pancreatic Cancer | Phase 1 | Status: WITHDRAWN